Improving Androgen-Deprivation Therapy for Prostate Cancer

Improving Androgen-Deprivation Therapy for Prostate Cancer

User Photo
roswellpark

3 years
771 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Dr. David Goodrich, Professor of Oncology at Roswell Park Cancer Institute, is co-author of a study offering new insights on preventing androgen-deprivation therapy resistance for prostate cancer. The research also examines the Rb1 and Ezh2 genes and their role in the occurrence of metastatic prostate cancer.
Up Next Autoplay